Twice-Yearly siRNA LDL Cholesterol Therapy: Trial Data and Supply Logistics for Indian Hospitals

Cholesterol-lowering injections are no longer all alike. Antibody PCSK9 inhibitors are given every two or four weeks. A newer class, small interfering RNA (siRNA), is given at much longer intervals. For hospital pharmacies, cardiology units and procurement teams in India, a six-monthly schedule changes how stock, recall and cold chain are planned. This article reports […]
